Home/Filings/4/0000950170-25-086231
4//SEC Filing

CHASE WILLIAM J 4

Accession 0000950170-25-086231

CIK 0001652130other

Filed

Jun 12, 8:00 PM ET

Accepted

Jun 13, 4:25 PM ET

Size

17.3 KB

Accession

0000950170-25-086231

Insider Transaction Report

Form 4
Period: 2025-06-11
Transactions
  • Award

    Common Stock

    2025-06-11+8,00034,693 total
  • Award

    Stock Option (right to buy)

    2025-06-11+11,45011,450 total
    Exercise: $8.37Exp: 2035-06-10Common Stock (11,450 underlying)
Footnotes (2)
  • [F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
  • [F2]This option was granted on June 11, 2025 with respect to 11,450 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.

Issuer

Intellia Therapeutics, Inc.

CIK 0001652130

Entity typeother

Related Parties

1
  • filerCIK 0001563572

Filing Metadata

Form type
4
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:25 PM ET
Size
17.3 KB